Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
申请人:Berger Richard
公开号:US08653260B2
公开(公告)日:2014-02-18
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
申请人:Merck Sharp & Dohme Corp.
公开号:US08247415B2
公开(公告)日:2012-08-21
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.